Cheng Cao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Cheng Cao has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Lei Shi
State Key Laboratory of Experimental Hematology, Key Laboratory of Cellular and Molecular Immunology in Tianjin, and Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin 300071, China
5 shared publications - Kai Zhang
Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China
4 shared publications - Fuquan Yang
College of Life Sciences, University of Chinese Academy of Sciences , Beijing, China
3 shared publications - Ling Liu
Key Laboratory of Breast Cancer Prevention and Therapy (Ministry of Education), National Key Laboratory of Blood Science, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Medical University, Tianjin, China
3 shared publications - Nan Song
Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
3 shared publications - Beibei Liu
Capital Medical University, China
2 shared publications
Latest Publications
- Open Access
- 2 September 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (17)
Corrigendum to Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
- 2 September 2025
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 135 (17)
Open AccessCorrigendum to Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
- Open Access
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (3) , 101036
Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability
- 1 September 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297 (3) , 101036
Open AccessEpithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability
- Open Access
- 7 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (19) , eabf7684
PHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stability
PHF8-promoted non-histone methylation switch plays a critical role in replication stress response and genome integrity.
- 7 May 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (19) , eabf7684
Open AccessPHF8-promoted TOPBP1 demethylation drives ATR activation and preserves genome stability
PHF8-promoted non-histone methylation switch plays a critical role in replication stress response and genome integrity.
- Open Access
- 1 June 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (25) , 9844-9857
USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis
- 1 June 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294 (25) , 9844-9857
Open AccessUSP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis
- Open Access
- 4 September 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (10) , 4280-4296
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Central to the recognition, signaling, and repair of DNA double-strand breaks (DSBs) are the MRE11-RAD50-NBS1 (MRN) complex and mediator of DNA damage checkpoint protein 1 (MDC1), the interplay of which is essential for initiation and amplification of the DNA damage response (DDR). The intrinsic rule governing the regulation of the function of this molecular machinery remains to be investigated. We report here that the ubiquitin-specific protease USP7 was physically associated with the MRN-MDC1 complex and that the MRN-MDC1 complex acted as a platform for USP7 to efficiently deubiquitinate and stabilize MDC1, thereby sustaining the DDR. Accordingly, depletion of USP7 impaired the engagement of the MRN-MDC1 complex and the consequent recruitment of the downstream factors p53-binding protein 1 (53BP1) and breast cancer protein 1 (BRCA1) at DNA lesions. Significantly, USP7 was overexpressed in cervical cancer, and the level of its expression positively correlated with that of MDC1 and worse survival rates for patients with cervical cancer. We demonstrate that USP7-mediated MDC1 stabilization promoted cervical cancer cell survival and conferred cellular resistance to genotoxic insults. Together, our study reveals a role for USP7 in regulating the function of the MRN-MDC1 complex and activity of the DDR, supporting the pursuit of USP7 as a potential therapeutic target for MDC1-proficient cancers.
- 4 September 2018
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 128 (10) , 4280-4296
Open AccessUbiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Central to the recognition, signaling, and repair of DNA double-strand breaks (DSBs) are the MRE11-RAD50-NBS1 (MRN) complex and mediator of DNA damage checkpoint protein 1 (MDC1), the interplay of which is essential for initiation and amplification of the DNA damage response (DDR). The intrinsic rule governing the regulation of the function of this molecular machinery remains to be investigated. We report here that the ubiquitin-specific protease USP7 was physically associated with the MRN-MDC1 complex and that the MRN-MDC1 complex acted as a platform for USP7 to efficiently deubiquitinate and stabilize MDC1, thereby sustaining the DDR. Accordingly, depletion of USP7 impaired the engagement of the MRN-MDC1 complex and the consequent recruitment of the downstream factors p53-binding protein 1 (53BP1) and breast cancer protein 1 (BRCA1) at DNA lesions. Significantly, USP7 was overexpressed in cervical cancer, and the level of its expression positively correlated with that of MDC1 and worse survival rates for patients with cervical cancer. We demonstrate that USP7-mediated MDC1 stabilization promoted cervical cancer cell survival and conferred cellular resistance to genotoxic insults. Together, our study reveals a role for USP7 in regulating the function of the MRN-MDC1 complex and activity of the DDR, supporting the pursuit of USP7 as a potential therapeutic target for MDC1-proficient cancers.